Given the critical role of mitogen-activated protein kinase (MAPK) pathways in regulating cellular processes that are affected in AD, the importance of MAPKs in disease pathogenesis is being increasingly recognized (Savage et al., 2002; Otth et al., 2003; Peel et al., 2004). Here, WNK2 is linked to Alzheimer disease.